Literature DB >> 12733958

Negative transcriptional regulation of connexin 43 by Tbx2 in rat immature coronal sutures and ROS 17/2.8 cells in culture.

James L Borke1, Jung-Ren Chen, Jack C Yu, Roni J Bollag, Maria F Orellana, Carlos M Isales.   

Abstract

BACKGROUND: Tbx2 is a member of the T-box family of transcriptional regulatory genes with an extensive but not yet fully understood role in embryonic development. This study explores the potential role of Tbx2 in calvarial morphogenesis.
OBJECTIVES: To explore the hypothesis that Tbx2 has a negative regulatory effect on the expression of connexin 43 (Cx43), a protein necessary for cell-to-cell communication; document the presence of Tbx2 protein in the developing cranial sutures; and determine the spatial pattern of expression of this developmentally regulated transcription factor in calvariae.
DESIGN: The osteoblast-like cell line ROS 17/2.8 was stably transfected with sense or antisense Tbx2. Immunohistochemistry and Western blotting was used to study Tbx2 and Cx43 expression in these cells and sections of embedded developing coronal sutures.
RESULTS: The ROS 17/2.8 cells transfected with antisense Tbx2 showed a decrease in expression of Tbx2 protein and an increase in expression of endogenous Cx43. The reverse is seen with sense-transfected cells. Both of these proteins are expressed in rat developing coronal sutures. The pattern of Tbx2 expression in the developing was also reciprocal to the pattern of Cx43 expression. Tbx2 protein is concentrated in the center of the sutural blastema, an area devoid of Cx43 protein localization. Conversely, Tbx2 protein expression is low in the periphery of the sutures, in which there is high Cx43 protein expression.
CONCLUSIONS: Taken together, these studies suggest that Tbx2 protein is a negative regulator of Cx43 expression at the transcriptional level in cranial sutures in vivo.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12733958     DOI: 10.1597/1545-1569_2003_040_0284_ntrocb_2.0.co_2

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  7 in total

1.  Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum.

Authors:  Anne Pizard; Patrick G Burgon; David L Paul; Benoit G Bruneau; Christine E Seidman; J G Seidman
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

2.  Channeling diversity: gap junction expression in the heart.

Authors:  Steven Giovannone; Benjamin F Remo; Glenn I Fishman
Journal:  Heart Rhythm       Date:  2011-11-23       Impact factor: 6.343

3.  Functional variants in TBX2 are associated with a syndromic cardiovascular and skeletal developmental disorder.

Authors:  Ning Liu; Kelly Schoch; Xi Luo; Loren D M Pena; Venkata Hemanjani Bhavana; Mary K Kukolich; Sarah Stringer; Zöe Powis; Kelly Radtke; Cameron Mroske; Kristen L Deak; Marie T McDonald; Allyn McConkie-Rosell; M Louise Markert; Peter G Kranz; Nicholas Stong; Anna C Need; David Bick; Michelle D Amaral; Elizabeth A Worthey; Shawn Levy; Michael F Wangler; Hugo J Bellen; Vandana Shashi; Shinya Yamamoto
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

4.  Loss of Tbx2 delays optic vesicle invagination leading to small optic cups.

Authors:  Hourinaz Behesti; Virginia E Papaioannou; Jane C Sowden
Journal:  Dev Biol       Date:  2009-07-01       Impact factor: 3.582

5.  Stretch force guides finger-like pattern of bone formation in suture.

Authors:  Bo-Hai Wu; Xiao-Xing Kou; Ci Zhang; Yi-Mei Zhang; Zhen Cui; Xue-Dong Wang; Yan Liu; Da-Wei Liu; Yan-Heng Zhou
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

6.  TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion.

Authors:  Yan Lv; Meng Si; Nannan Chen; Ya Li; Xingkai Ma; Huijun Yang; Ling Zhang; Hongyan Zhu; Guang-Yin Xu; Ge-Ping Wu; C Cao
Journal:  Oncotarget       Date:  2017-04-13

Review 7.  Recent Developments in Using Drosophila as a Model for Human Genetic Disease.

Authors:  Christine Oriel; Paul Lasko
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.